Literature DB >> 16966551

Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype.

H Rauschka1, B Colsch, N Baumann, R Wevers, M Schmidbauer, M Krammer, J-C Turpin, M Lefevre, C Olivier, S Tardieu, W Krivit, H Moser, A Moser, V Gieselmann, B Zalc, T Cox, U Reuner, A Tylki-Szymanska, F Aboul-Enein, E LeGuern, H Bernheimer, J Berger.   

Abstract

BACKGROUND: P426L and I179S are the two most frequent mutations in juvenile and adult metachromatic leukodystrophy (late-onset MLD), which, in contrast to infantile MLD, show marked phenotypic heterogeneity.
OBJECTIVE: To search for genotype-phenotype correlations in late-onset MLD.
METHODS: The authors reviewed the clinical course of 22 patients homozygous for mutation P426L vs 20 patients heterozygous for mutation I179S, in which the second arylsulfatase A (ASA) mutation had also been determined.
RESULTS: P426L homozygotes principally presented with progressive gait disturbance caused by spastic paraparesis or cerebellar ataxia; mental disturbance was absent or insignificant at the onset of disease but became more apparent as the disease evolved. In contrast, compound heterozygotes for I179S presented with schizophrenia-like behavioral abnormalities, social dysfunction, and mental decline, but motor deficits were scarce. Reduced peripheral nerve conduction velocities and less residual ASA activity were present in P426L homozygotes vs I179S heterozygotes.
CONCLUSION: The characteristic clinical differences between homozygous P426L and compound heterozygous I179S patients establish a distinct genotype-phenotype correlation in late-onset metachromatic leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966551     DOI: 10.1212/01.wnl.0000234129.97727.4d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Gene therapy for metachromatic leukodystrophy.

Authors:  Jonathan B Rosenberg; Stephen M Kaminsky; Patrick Aubourg; Ronald G Crystal; Dolan Sondhi
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 2.  Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature.

Authors:  Asif Mahmood; Jay Berry; David A Wenger; Maria Escolar; Magdi Sobeih; Gerald Raymond; Florian S Eichler
Journal:  J Child Neurol       Date:  2009-12-28       Impact factor: 1.987

3.  Metachromatic leukodystrophy with late adult-onset: diagnostic clues and differences from other genetic leukoencephalopathies with dementia.

Authors:  Chiara Benzoni; Marco Moscatelli; Silvia Fenu; Anna Venerando; Ettore Salsano
Journal:  J Neurol       Date:  2021-01-08       Impact factor: 4.849

Review 4.  Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways.

Authors:  Matthis Synofzik; Rebecca Schüle
Journal:  Mov Disord       Date:  2017-02-14       Impact factor: 10.338

5.  Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates.

Authors:  Jonathan B Rosenberg; Dolan Sondhi; David G Rubin; Sébastien Monette; Alvin Chen; Sara Cram; Bishnu P De; Stephen M Kaminsky; Caroline Sevin; Patrick Aubourg; Ronald G Crystal
Journal:  Hum Gene Ther Clin Dev       Date:  2014-08-21       Impact factor: 5.032

6.  Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy.

Authors:  Nicholas J Smith; Robert E Marcus; Barbara J Sahakian; Narinder Kapur; Timothy M Cox
Journal:  J Inherit Metab Dis       Date:  2010-11-16       Impact factor: 4.982

Review 7.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach.

Authors:  F Sedel; B Fontaine; J M Saudubray; O Lyon-Caen
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

Review 8.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

9.  Geriatric neurogenetics: oxymoron or reality?

Authors:  Thomas D Bird; Hillary P Lipe; Ellen J Steinbart
Journal:  Arch Neurol       Date:  2008-04

10.  Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies.

Authors:  Yanli Cui; Benoit Colsch; Carlos Afonso; Carlos Alonso; Nicole Baumann; Jean-Claude Tabet; Jean-Maurice Mallet; Yongmin Zhang
Journal:  Glycoconj J       Date:  2007-08-15       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.